A typical tirzepatide dosage chart outlines how treatment begins with a low weekly dose before gradually increasing in stages. This step-up approach helps improve tolerance and allows providers to monitor how the body responds before moving to higher doses.
Many people still feel confused about how this schedule actually works. When starting tirzepatide, it helps to understand when doses increase, how long each stage lasts, and why providers follow this structured progression.
In this guide, we break down the tirzepatide dosage chart, explain how the weekly dosing schedule progresses, and show how providers use this framework to guide safe and effective treatment.
beyondMD providers design personalized tirzepatide dosing plans using structured dose escalation. Choose between medically guided Zepbound® or compounded tirzepatide programs.
Key Takeaways
- A tirzepatide dosage chart shows how treatment begins with a low weekly dose and gradually increases over time.
- Most tirzepatide programs start at 2.5 mg once weekly before moving to higher doses in structured steps.
- Providers typically increase the dose every four weeks to help the body adjust and improve tolerance.
- Not everyone reaches the highest dose—providers adjust the tirzepatide dosage chart based on response and side effects.
- Provider guidance helps ensure the dosing schedule remains safe, effective, and personalized for each patient.
The Tirzepatide Dosage Chart
Below is a simplified example of how a typical tirzepatide dosage chart progresses during treatment.

Providers may adjust the dosage depending on how a patient responds to treatment. Some people remain at lower doses, while others progress through the full dosing schedule.
What Happens at Each Stage of the Tirzepatide Dosage Chart
Weeks 1–4: Starting Dose (2.5 mg Once Weekly)
The tirzepatide dosage chart begins with a starting dose of 2.5 mg once weekly. This introductory phase allows the body to adjust to the medication. Providers use this stage to reduce the likelihood of gastrointestinal side effects while monitoring how patients respond to treatment.
Weeks 5–8: First Dose Increase (5 mg Once Weekly)
Weeks 9–12: Continued Dose Escalation (7.5 mg Once Weekly)
Weeks 13–16: Higher Therapeutic Dose (10 mg Once Weekly)
Weeks 17–20: Additional Dose Escalation (12.5 mg Once Weekly)
Week 21 and Beyond: Maximum Dose (15 mg Once Weekly)
The maximum dose in the tirzepatide dosage chart is 15 mg once weekly. However, not everyone reaches this level. Providers determine whether to continue increasing the dose based on patient response, tolerance, and treatment goals.
Why Tirzepatide Doses Increase Gradually

Gradual dose escalation also helps reduce common side effects, particularly gastrointestinal symptoms that can occur when starting GLP-1 and GIP therapies.
beyondMD
By increasing the dose every few weeks, providers can evaluate how the body responds before moving to the next level.
In addition, the tirzepatide dosage chart allows providers to personalize treatment. Some patients achieve strong results at moderate doses, while others may continue increasing to higher levels depending on response and treatment goals.
Explore More GLP-1 Resources
- Wegovy® Dosing: Schedule, Titration, and What to Expect:
Understand how Wegovy dosing increases over time and how its titration schedule compares to other GLP-1 therapies. - Semaglutide vs Tirzepatide: Key Differences and What to Consider:
Learn how these two GLP-1 medications differ in mechanism, dosing, and treatment outcomes. - How GLP-1s Work: What Happens Inside Your Body:
Explore how GLP-1 medications regulate appetite, metabolism, and blood sugar at the biological level. - WHO Guidelines on GLP-1 Therapies: The 5 Things You Need to Know:
Review the latest global guidance and recommendations on GLP-1 treatments. - Best Peptides for Weight Loss: Find the Right Treatment for Fast, Clinically Proven Results:
Discover peptide therapies commonly used in medical weight management programs. - The Mental Health Effects of GLP-1 Drugs: What We’re Learning—and What You Should Know:
Understand emerging research on how GLP-1 medications may influence mood, behavior, and mental health.


